Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Deciphera Pharmaceuticals at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Deciphera Pharmaceuticals exhibits at Booth 3731 at ASH 2026 in New Orleans. Deciphera Pharmaceuticals supports a symposium on primary central nervous system lymphoma. Run as a live tumor board, it works through the disease's molecular pathways and the therapies now emerging for it.

OrganizationASH 2026 Attendance
deciphera.com
Biotech1 exhibitor meeting room
Oncology company owned by Ono Pharmaceutical, developing and marketing kinase-inhibitor cancer medicines.
Booth
Exhibiting at Booth 3731
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
3:00pm–6:00pm
Live Tumor Board: Advancing Clinical Competence in Primary CNS Lymphoma — Navigating Molecular Pathways and Emerging Therapies
Treating primary central nervous system lymphoma, from methotrexate-based induction and consolidation choices to new drugs aimed at its signaling mutations.
Convention Center · La Nouvelle C
Lymphoma

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Deciphera Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction